Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes

Movement Disorders : Official Journal of the Movement Disorder Society
Ana M CatafauDaTSCAN Clinically Uncertain Parkinsonian Syndromes Study Group

Abstract

Imaging with (123)I-Ioflupane single-photon emission computed tomography (SPECT) is a marker of nigrostriatal neuronal integrity, allowing differentiation of parkinsonism with loss of dopaminergic terminals (presynaptic Parkinson syndrome [PS]) from parkinsonism without nigrostriatal degeneration. This study assessed SPECT imaging in 118 patients with clinically uncertain parkinsonian syndromes (CUPS). In 36% of patients with presynaptic PS and 54% with nonpresynaptic PS, imaging results were not consistent with the initial diagnosis. After imaging, diagnosis was changed in 52% of patients. All patients with a final diagnosis of presynaptic PS had an abnormal image, whereas 94% of patients with nonpresynaptic PS had a normal scan. Imaging increased confidence in diagnosis, leading to changes in clinical management in 72% of patients. Consequently, visual assessment of (123)I-Ioflupane SPECT may have a significant impact on the clinical management of CUPS patients.

References

Mar 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·A J HughesA J Lees
Aug 1, 1991·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·A H RajputA Rajput
Feb 18, 1995·BMJ : British Medical Journal·N Quinn
Mar 14, 2000·Archives of Neurology·J JankovicD P Perl
Nov 30, 2002·European Journal of Nuclear Medicine and Molecular Imaging·Annemette LøkkegaardLars Friberg
May 1, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·Hani T S BenamerV Ries

❮ Previous
Next ❯

Citations

Oct 31, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Jan Booij, Paul Kemp
Oct 29, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Francisco J Diaz-CorralesPablo Mir
Jan 13, 2012·Annals of Nuclear Medicine·Nikolaos PapathanasiouIoannis Datseris
Jan 29, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Joseph C Masdeu
Apr 3, 2008·Nature Clinical Practice. Neurology·David J Brooks
Aug 4, 2011·Brain : a Journal of Neurology·Jeffrey L CummingsPaul Kemp
Nov 8, 2006·Nuclear Medicine Communications·Vicky L MarshallDonald G Grosset
Dec 25, 2009·Nuclear Medicine Communications·Alp NotghiWilliam H Thomson
Jul 9, 2010·Nuclear Medicine Communications·Marianne C TondeurHamphrey R Ham
Jan 7, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C RossiR Ceravolo
Oct 16, 2010·Biomarkers in Medicine·David J Brooks
Aug 16, 2013·Journal of Neurology, Neurosurgery, and Psychiatry·J J McKinleyT Lynch
Oct 29, 2013·BioMed Research International·Susanna Jakobson MoKatrine Riklund
Jun 6, 2014·Nuclear Medicine and Molecular Imaging·Eunkyung ParkKun Woo Park
Jun 5, 2014·European Journal of Nuclear Medicine and Molecular Imaging·Monique R BernsenMarion de Jong
Apr 7, 2011·European Journal of Nuclear Medicine and Molecular Imaging·Livia Tossici-BoltAndrea Varrone
Apr 4, 2008·European Journal of Nuclear Medicine and Molecular Imaging·Koen Van LaereThierry Vander Borght
Feb 20, 2008·European Journal of Nuclear Medicine and Molecular Imaging·Andrea VarroneMarco Salvatore
Mar 1, 2011·Expert Opinion on Medical Diagnostics·Raúl de la Fuente-FernándezVesna Sossi
Sep 6, 2015·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Nicolas NicastroPierre R Burkhard
May 17, 2008·CNS Neuroscience & Therapeutics·Patrick EmondSylvie Chalon
Jul 4, 2015·Brain : a Journal of Neurology·Aurelija JucaiteLars Farde
Feb 5, 2015·Journal of Neurology·Claire ThiriezPhilippe Remy
Aug 29, 2014·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Ivanka Stenc BradvicaPatricia Reisz-Majić
Jun 7, 2014·AJNR. American Journal of Neuroradiology·T C BoothJ Buscombe
Jun 14, 2014·AJNR. American Journal of Neuroradiology·T C BoothJ Buscombe
Sep 8, 2011·Progress in Neurobiology·David J Brooks, Nicola Pavese
Nov 5, 2016·Expert Review of Neurotherapeutics·Stuart H IsaacsonJohn Seibyl
Apr 9, 2017·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Jun UedaNobuo Kohara
Dec 20, 2005·Lancet Neurology·Eduardo TolosaWerner Poewe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atypical Parkinsonism (MDS)

Atypical Parkinsonism presents with the same signs and symptoms of Parkinson's disease, but do not respond to typical Parkionson's disease treatment with levodopa. Atypical Parkinsonism is thought to be associated with abnormal protein buildup within brain cells. Here is the latest on Atypical Parkinsonism.